Easier access to compassionate end-of-life care is now available for patients and families in Fort Worth and surrounding ...
Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback